首页> 外文期刊>Bioorganic and Medicinal Chemistry Letters >Discovery of novel 4-phenyl-2-(pyrrolidinyl)nicotinamide derivatives as potent Na(v)1.1 activators
【24h】

Discovery of novel 4-phenyl-2-(pyrrolidinyl)nicotinamide derivatives as potent Na(v)1.1 activators

机译:发现新型4-苯基-2-(吡咯烷基)烟酰胺衍生物作为有效的Na(v)1.1活化剂

获取原文
获取原文并翻译 | 示例
           

摘要

The voltage-gated sodium channel, Na(v)1.1, is predominantly expressed in parvalbumin-positive fast spiking interneurons and has been genetically linked to Dravet syndrome. Starting from a high throughput screening hit isoxazole derivative 5, modifications of 5 via combinations of IonWorks and Q-patch assays successfully identified the nicotinamide derivative 4. Its increasing decay time constant (tau) of Na(v)1.1 currents at 0.03 mu M along with significant selectivity against Na(v)1.2, Na(v)1.5, and Na(v)1.6 and acceptable brain exposure in mice was observed. Compound 4 is a promising Na(v)1.1 activator that can be used to analyze pathophysiological functions of the Na(v)1.1 channel towards treating various central nervous system diseases.
机译:电压门控钠通道Na(v)1.1主要在Parvalbumin-阳性快速尖刺的中间核中表达,并且已与Dravet综合征遗传相关。 从高通量筛选的起始异恶唑衍生物5开始,通过IONOrdworks和Q蛋白测定的组合来改变5的修饰,成功地鉴定了烟胺酰胺衍生物4.其Na(V)的衰减时间常数(TAU)为0.03μm 观察到具有针对Na(v)1.2,Na(v)1.5和Na(v)1.6的显着选择性,并观察到小鼠的可接受的脑暴露。 化合物4是一种有前途的Na(v)1.1活化剂,可用于分析Na(v)1.1通道的病理生理功能朝向治疗各种中枢神经系统疾病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号